South Africa Immunosuppressant Drugs Market Size & Outlook
Related Markets
South Africa immunosuppressant drugs market highlights
- The South Africa immunosuppressant drugs market generated a revenue of USD 1,193.5 million in 2020 and is expected to reach USD 1,823.7 million by 2027.
- The South Africa market is expected to grow at a CAGR of 6.2% from 2021 to 2027.
- In terms of segment, monoclonal antibodies was the largest revenue generating drug class in 2020.
- Monoclonal Antibodies is the most lucrative drug class segment registering the fastest growth during the forecast period.
Immunosuppressant drugs market data book summary
| Market revenue in 2020 | USD 1,193.5 million |
| Market revenue in 2027 | USD 1,823.7 million |
| Growth rate | 6.2% (CAGR from 2020 to 2027) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Monoclonal Antibodies |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Calcineurin Inhibitors, MTOR Inhibitors, Antiproliferative Agents, Monoclonal Antibodies |
Other key industry trends
- In terms of revenue, South Africa accounted for 1.2% of the global immunosuppressant drugs market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Middle East & Africa, Saudi Arabia immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 2,291.3 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunosuppressant Drugs Market Scope
Immunosuppressant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| No records found. | ||||
South Africa immunosuppressant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunosuppressant drugs market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 71.42% in 2020. Horizon Databook has segmented the South Africa immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
Rising geriatric population at unprecedented rate has led to high prevalence of age-related dental disorders, hence fostering the growth of this industry. According to NCBI, dental caries is the most prevalent oral disease in SA and almost 60% of the geriatric population above 60 years have had dental caries.
According to National Library of Medicine, majority of South Africans have no access to private services and are dependent on the government for oral health care services, but less than 10% of the population utilizes public oral health services and this underutilization is due to limited resources and inaccessibility.
South Africa is a middle income country and the highest prevalence is of HIV/AIDS infecting about 5.7 million people in the country with a prevalence rate of 12%. The high prevalence of hepatitis and HIV/AIDS infection poses a higher risk to oral health. Moreover, South Africa has dire scarcity of medical and dental professionals.
Reasons to subscribe to South Africa immunosuppressant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa immunosuppressant drugs market databook
-
Our clientele includes a mix of immunosuppressant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa immunosuppressant drugs market, including forecasts for subscribers. This country databook contains high-level insights into South Africa immunosuppressant drugs market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa immunosuppressant drugs market size, by drug class, 2016-2027 (US$M)
South Africa Immunosuppressant Drugs Market Share, 2020 & 2027 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
